FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1553-1554 November 19, 1998 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Pastuszak, A. L. Related Article by Pastuszak, A. L. PubMed Citation

To the Editor: In their paper describing the association between the reported use of misoprostol in unsuccessful attempts to terminate pregnancy and Möbius' syndrome in infants, Pastuszak et al. (June 25 issue)¹ conclude that the "administration of misoprostol during pregnancy should be strongly discouraged, given the drug's low efficacy and its likelihood of causing fetal malformations." We disagree. The suitability of administering misoprostol during pregnancy depends entirely on the intended effect. If the desired outcome is the medical termination of unwanted pregnancy, cervical priming before vacuum aspiration, or prevention of postpartum hemorrhage, concern about potential fetal malformation is misplaced, and . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Cattaneo, L., Chierici, E., Bianchi, B., Sesenna, E., Pavesi, G. (2006). The localization of facial motor impairment in sporadic Mobius syndrome. Neurology 66: 1907-1912 [Abstract] [Full Text]